Fig. 2: Schematic overview of the feasibility of PK-guided interventions. | British Journal of Cancer

Fig. 2: Schematic overview of the feasibility of PK-guided interventions.

From: Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients

Fig. 2

Data are expressed as number (N) and percentage (%). Patients had ≥1 low PK level or all adequate PK levels. Patients with ≥1 low PK level did or did not have a PK-guided intervention. This PK-guided intervention was either successful or not successful. If patients had no PK-guided intervention, the reason why was stated. If patients had all adequate PK levels, it was stated if the standard dose was continued throughout the study, or dose reduction/dose interruption/end of treatment was necessary as a result of treatment related toxicity. PK pharmacokinetic.

Back to article page